WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
I
N
Vol. 38 No.6 • 10/2020
T
Protein Biomarker for Risk of liver Disease
R
esults obtained during a recent study suggest that neuronal regeneration related protein (NREP) can be used as an early biomarker for the detection of nonalcoholic fatty liver disease (NAFLD). NAFLD is the most common
Cont’d on page 16
E
R
N
A
T
A
n extraction-free, direct sample addition RT-PCR test for the detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19 has the potential to increase testing capacity by millions per week. BioGX Inc. (Birmingham, AL,
Researchers testing alternative ways to measure COVID19 antibody levels have developed a process that is faster, easier and less expensive to use on a large scale, and holds promise for accurately identifying potential donors who have the best chance of helping infected patients through convalescent plasma therapy. LabMedica’s COVID-19 Diagnostics Update section starts on page 4.
V
I
S
I
T
lINKXPReSS COM
R E A D E R
S E R V I C E
®
P O R T A L
Renew /Start your Free Subscription
access Interactive Digital Magazine
Instant Online Product Information:
Identify linkXpress codes of 1 interest as you read magazine ®
on linkXpress.com 2 toClick reach reader service portal
code(s) of interest on 3 Mark linkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
O
Simple RT-PCR Test for COVID-19 Could Raise Testing Capacity by Millions per week
USA; www.biogx.com) has applied for Emergency Use Authorization (EUA) with the US Food and Drug Administration (FDA) for its extraction-free, direct sample addition RT-PCR test for the detection of SARS-CoV-2 viral RNA in suspected COVID-19 Cont’d on page 20
New Testing Process Could Revolutionize Measurement of COVID-19 antibody levels
See article on page 23
I
N
A
®
L
Test Predicts Kidney Transplant Failure
T
cells recognize foreign or aberrant antigens presented by major histocompatibility complex (MHC-I) expressing cells through the T cell receptor (TCR) and is the first critical step towards establishment of protective immunity against viruses and tumors. Staining with multivalent MHC class-I reagents (multimers) followed by flow cytometry is
COVID-19 Testing without Reagents
A
Clinical Studies Confirm FDa Data for abbott's COVID-19 Rapid Test
A
bbott Diagnostics has shared new interim clinical data results on its ID NOW COVID-19 rapid test that confirm the data submitted to the US Food and Drug Administration (FDA) in March for Emergency Use Authorization (EUA) and the interim results shared in its May 21 press release.
Cont’d on page 25
Serology assay Rapidly Characterizes Immune Response to SaRS-CoV-2 antigens
A
DaIly ClINICal laB NewS
Cont’d on page 22
Image: New Testing Process Could Simplify Measuring COVID-19 Antibody Levels (Photo courtesy of USAMRIID VIO)
new SARS-CoV-2 multi-antigen assay for Simple Western offers quantitative characterization of patient serum or plasma derived human IgG antibodies reactive against recombinant Nucleocapsid protein (N), S1 receptor binding domain protein (RBD), S1
V I S I T
subunit full length, S2 subunit full length, and Spike (S1+S2) viral antigens within one 3-hour run. Bio-Techne Corporation (Minneapolis, MN, USA; www.bio-tech ne.com) has launched its SARSCoV-2 Multi-Antigen Serology Module for Jess and Wes Simple Cont’d on page 27
newly-developed COVID-19 testing method that does not make use of key chemicals, or reagents, but still delivers accurate results, could pave the way for inexpensive, widely available testing amidst the supply shortage of reagent supplies globally. A team of scientists at the University of Vermont (Burlington, VT, USA; www.uvm.edu), working in partnership with a group Cont’d on page 20
INSIDE
COVID-19 Update . . . . . 4 Clinical News . . . . . . . . . 8 IFCC News . . . . . . . . . . 25 Product News . . . . . 6-24 Events Calendar . . 30-31
PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GlOBeTeCH >>> MeDIa <<<